NDC 70720-951

ZOLADEX

Goserelin Acetate

ZOLADEX is a Subcutaneous Implant in the Human Prescription Drug category. It is labeled and distributed by Tersera Therapeutics Llc. The primary component is Goserelin Acetate.

• Product ID: 70720-951_0e4036b4-e4a4-4dc9-891c-dc11802c6ea7
• NDC: 70720-951
• Product Type: Human Prescription Drug
• Proprietary Name: ZOLADEX
• Generic Name: Goserelin Acetate
• Dosage Form: Implant
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2018-01-26
• Marketing Category: NDA / NDA
• Application Number: NDA020578
• Labeler Name: TerSera Therapeutics LLC
• Substance Name: GOSERELIN ACETATE
• Active Ingredient Strength: 11 mg/1
• Pharm Classes: Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 70720-951-30

1 POUCH in 1 CARTON (70720-951-30) > 1 SYRINGE in 1 POUCH > 1 IMPLANT in 1 SYRINGE

• Marketing Start Date: 2018-01-26
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 70720-951-30 [70720095130]

ZOLADEX IMPLANT

• Marketing Category: NDA
• Application Number: NDA020578
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2018-01-26

Drug Details

Active Ingredients

Ingredient	Strength
GOSERELIN ACETATE	10.8 mg/1

OpenFDA Data

• SPL SET ID: e4cb3c20-2738-400a-b522-3f36f71fe6c5
• Manufacturer:
  • TerSera Therapeutics LLC
• UNII:
  • 6YUU2PV0U8
• RxNorm Concept Unique ID - RxCUI:
  • 314008
  • 211544

Pharmacological Class

• Gonadotropin Releasing Hormone Receptor Agonist [EPC]
• Gonadotropin Releasing Hormone Receptor Agonists [MoA]

NDC Crossover Matching brand name "ZOLADEX" or generic name "Goserelin Acetate"

NDC	Brand Name	Generic Name
0310-0950	ZOLADEX	Goserelin acetate
0310-0951	ZOLADEX	Goserelin acetate
50090-2027	ZOLADEX	Goserelin acetate
50090-3466	ZOLADEX	goserelin acetate
70720-950	ZOLADEX	goserelin acetate
70720-951	ZOLADEX	goserelin acetate